Get started
RocketTickers

Eiger BioPharmaceuticals Announces Positive Results in Phase 2

Long
RocketTickers  
NASDAQ:EIGR   None
Beyond Technical Analysis
1
0
beyondta
EIGR: Eiger BioPharmaceuticals, Inc.
2018-10-16 16:05:00
Eiger BioPharmaceuticals Announces Positive Results in Phase 2 PREVENT Study of Avexitide Targeting GLP-1 in Post-Bariatric Hypoglycemia (PBH)
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.